A Novel BRISC-SHMT Complex Deubiquitinates IFNAR1 and Regulates Interferon Responses

Por Zheng, Hui, Gupta, Vibhor, Patterson-Fortin, Jeffrey, Bhattacharya, Sabyasachi, Katlinski, Kanstantsin, Wu, Junmin, Varghese, Bentley, Carbone, Christopher J., Aressy, Bernadette, Fuchs, Serge Y., Greenberg, Roger A.
Publicado em 2013

Type I interferons mediate pancreatic toxicities of PERK inhibition

Por Yu, Qiujing, Zhao, Bin, Gui, Jun, Katlinski, Kanstantsin V., Brice, Angela, Gao, Yan, Li, ChangHong, Kushner, Jake A., Koumenis, Constantinos, Diehl, J. Alan, Fuchs, Serge Y.
Publicado no Proc Natl Acad Sci U S A (2015)

Therapeutic elimination of the type 1 interferon receptor for treating psoriatic skin inflammation

Por Gui, Jun, Gober, Michael, Yang, Xiaoping, Katlinski, Kanstantsin V., Marshall, Christine M., Sharma, Meena, Werth, Victoria P., Baker, Darren P., Rui, Hallgeir, Seykora, John T., Fuchs, Serge Y.
Publicado no J Invest Dermatol (2016)

Type I Interferons Control Proliferation and Function of the Intestinal Epithelium

Por Katlinskaya, Yuliya V., Katlinski, Kanstantsin V., Lasri, Audrey, Li, Ning, Beiting, Daniel P., Durham, Amy C., Yang, Ting, Pikarsky, Eli, Lengner, Christopher J., Johnson, F. Brad, Ben-Neriah, Yinon, Fuchs, Serge Y.
Publicado no Mol Cell Biol (2016)

Suppression of type I interferon signaling overcomes oncogene-induced senescence and mediates melanoma development and progression

Por Katlinskaya, Yuliya V., Katlinski, Kanstantsin V., Yu, Qiujing, Ortiz, Angelica, Beiting, Daniel P., Brice, Angela, Davar, Diwakar, Sanders, Cindy, Kirkwood, John M., Rui, Hallgeir, Xu, Xiaowei, Koumenis, Constantinos, Diehl, J. Alan, Fuchs, Serge Y.
Publicado no Cell Rep (2016)

DNA damage-induced type I interferon promotes senescence and inhibits stem cell function

Por Yu, Qiujing, Katlinskaya, Yuliya V., Carbone, Christopher J., Zhao, Bin, Katlinski, Kanstantsin V., Zheng, Hui, Guha, Manti, Li, Ning, Chen, Qijun, Yang, Ting, Lengner, Christopher J., Greenberg, Roger A., Johnson, F. Brad, Fuchs, Serge Y.
Publicado no Cell Rep (2015)

Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment

Por Katlinski, Kanstantsin V., Gui, Jun, Katlinskaya, Yuliya V., Ortiz, Angelíca, Chakraborty, Riddhita, Bhattacharya, Sabyasachi, Carbone, Christopher J., Beiting, Daniel P., Girondo, Melanie A., Peck, Amy R., Puré, Ellen, Chatterji, Priya, Rustgi, Anil K., Diehl, J. Alan, Koumenis, Constantinos, Rui, Hallgeir, Fuchs, Serge Y.
Publicado no Cancer Cell (2017)

Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury

Por Bhattacharya, Sabyasachi, Katlinski, Kanstantsin V, Reichert, Maximilian, Takano, Shigetsugu, Brice, Angela, Zhao, Bin, Yu, Qiujing, Zheng, Hui, Carbone, Christopher J, Katlinskaya, Yuliya V, Leu, N Adrian, McCorkell, Kelly A, Srinivasan, Satish, Girondo, Melanie, Rui, Hallgeir, May, Michael J, Avadhani, Narayan G, Rustgi, Anil K, Fuchs, Serge Y
Publicado em 2014

A potent in vivo anti-tumor efficacy of novel recombinant type I interferon

Por Zhang, Kang-Jian, Yin, Xiao-Fei, Yang, Yuan-Qin, Li, Hui-Ling, Xu, Yan-Ni, Chen, Lie-Yang, Liu, Xi-Jun, Yuan, Su-Jing, Fang, Xian-Long, Xiao, Jing, Wu, Shuai, Xu, Hai-Neng, Chu, Liang, Katlinski, Kanstantsin V., Katlinskaya, Yuliya V., Guo, Rong-Bing, Wei, Guang-Wen, Wang, Da-Cheng, Liu, Xin-Yuan, Fuchs, Serge Y.
Publicado no Clin Cancer Res (2016)